Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:1138
SEHK:1138Oil and Gas

COSCO SHIPPING Energy Transportation (SEHK:1138): Net Margin Edge Reinforces Bullish Case Despite Slower Earnings Growth

COSCO SHIPPING Energy Transportation (SEHK:1138) reported average annual earnings growth of 31.9% over the past five years, with net profit margins currently at 14.2%, up from 13.9% last year. The most recent year saw earnings growth of 1.7%, and the company is presently trading at a Price-To-Earnings ratio of 16.8x. This valuation appears more attractive than peer averages, although it remains higher than the Hong Kong oil and gas industry benchmark. Looking ahead, forecasts for 11.31%...
SEHK:1288
SEHK:1288Banks

Agricultural Bank of China (SEHK:1288) Net Profit Margin Tops Narrative as Growth Trails Market

Agricultural Bank of China (SEHK:1288) posted a net profit margin of 45% for the latest period, edging ahead of last year’s 44.3%. Earnings grew 5.8% over the past year, outpacing its five-year average of 5.5% per year. The share price closed at HK$5.92, well below the estimated fair value of HK$11.21 based on discounted cash flow. Earnings are forecast to rise at 3.6% annually in the coming years. The bank stands out for its attractive dividends and high-quality past profits, even as its...
NasdaqCM:MDXG
NasdaqCM:MDXGBiotechs

MiMedx Group (MDXG) Margin Decline Raises Questions on Profitability Narrative

MiMedx Group (MDXG) posted annual earnings growth projections of 15.73% and revenue growth set at 6.7% per year, even as its net profit margin slipped to 10.4% from last year’s 23.2%. Despite a shortfall in earnings growth over the past year, the company has built a solid five-year track record with average annual earnings growth of 67.7% and high-quality current profits. Shares trade at $7.40, notably below the assessed fair value of $16.75. This presents a potential value opportunity, but...
NYSE:FSS
NYSE:FSSMachinery

Federal Signal (FSS): Margin Holds at 11.2%, Supporting Ongoing Premium Valuation Debate

Federal Signal (FSS) maintained a steady net profit margin of 11.2% year over year, underscoring consistent profitability. Over the last five years, the company’s earnings have grown at an average rate of 21.2% annually, but growth eased to 9.6% in the most recent year. Looking forward, analysts expect earnings to climb 11.8% per year and revenue to grow at 10.8% per year, outpacing the broader US market’s 10.3% forecast. With its current share price below DCF-based fair value and trading at...
ENXTLS:BCP
ENXTLS:BCPBanks

BCP (ENXTLS:BCP): €649.9 Million One-Off Loss Fuels Concerns Over Earnings Quality

Banco Comercial Português (ENXTLS:BCP) reported net profit margins of 25.5%, nearly matching last year’s 26.1%. A one-off €649.9 million loss weighed on its earnings for the twelve months ending September 30, 2025. Looking ahead, BCP is expected to deliver earnings growth of 9.57% per year and revenue growth of 3.8% per year, outpacing the Portuguese market’s 3.3% forecast for revenue growth. This forward-looking growth, combined with a share price trading below estimated fair value, could...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health (TDOC): Ongoing Losses Persist, Testing Value Narrative at 0.6x Price-to-Sales

Teladoc Health (TDOC) remains unprofitable, with forecasts indicating no expectation of profitability over the next three years. The company has narrowed its losses at a 12% annual rate over the past five years, while revenue is projected to increase by 2.3% per year. This revenue growth rate trails the US market average of 10.3%. Despite ongoing net losses and a stagnant profit margin, shares currently trade at a Price-to-Sales Ratio of 0.6x. This is well below both the US Healthcare...
NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

Preformed Line Products (PLPC) Earnings Growth Accelerates, Reinforcing Bullish Consistency Narratives

Preformed Line Products (PLPC) delivered 13.1% earnings growth over the past year, outpacing its own five-year average growth rate of 5.3% per year. Forward-looking estimates suggest earnings are set to grow by 12.46% per year and revenue by 6.1% annually. However, both are expected to trail the wider US market’s growth. Despite a net profit margin that has dipped slightly to 5.6%, investors will note the company's price-to-earnings ratio of 28.9x, which is below electrical industry and peer...
BIT:AMP
BIT:AMPHealthcare

Amplifon (BIT:AMP) Margin Decline Challenges Bull Case Despite Revenue Growth Outlook

Amplifon (BIT:AMP) is expecting its earnings to grow at 15.3% per year, with revenue projected to increase 5.7% annually. This outpaces the broader Italian market's 5.2% forecast. However, the company's net profit margin stands at 5.2%, down from 7% last year, and it recorded negative earnings growth over the past year despite averaging 3.6% annual growth over the past five years. With shares trading at €14.72, below the estimated fair value, investors are watching closely as the company...
NasdaqGS:VMEO
NasdaqGS:VMEOInteractive Media and Services

Should Vimeo’s (VMEO) AI-Powered Upgrade and Earnings Miss Shape Investors’ Long-Term Perspective?

Vimeo recently unveiled a major update to its video platform, introducing advanced AI-powered creative tools and collaborative features at its second annual REFRAME conference in New York, while also reporting third quarter earnings showing sales of US$105.76 million and a shift to a net loss. This combination of transformative platform enhancements and subdued financial performance highlights both the company's push for innovation and the operational pressures faced during this...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM): Losses Widen 27%, High Revenue Growth Sets Stage for Profitability Debate

Insmed (INSM) remains unprofitable, with losses widening at an annualized rate of 27.2% over the past five years and no improvement in its net profit margin. Yet, the company is generating excitement for its future growth, with revenue forecast to surge 44.4% per year and earnings projected to grow 78.55% annually. This suggests that Insmed could turn profitable within the next three years, a milestone the market could interpret as a potential inflection point. See our full analysis for...
ENXTPA:VIV
ENXTPA:VIVEntertainment

Vivendi (ENXTPA:VIV) Valuation Update Following New Financial Results and Gameloft-Driven Growth

Vivendi (ENXTPA:VIV) released its latest unaudited financial results, highlighting a small dip in third quarter revenue, but a 5% rise for the first nine months, thanks largely to Gameloft’s improved numbers. See our latest analysis for Vivendi. Vivendi’s solid revenue growth from Gameloft has helped brighten its broader narrative, and investors seem to have noticed. Despite some recent softness, with a 4.57% drop in the past week, the stock’s total shareholder return of 43.61% over the past...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy (ETSY) Margin Miss Challenges Optimistic Narratives After $106.8 Million One-Off Loss

Etsy (ETSY) reported a net profit margin of 6.4%, down from last year’s 9.2%, and disclosed that earnings have declined 9.1% per year over the past five years. The company was hit by a significant one-off loss of $106.8 million for the twelve months to September 30, 2025, but analysts are looking for a turnaround with profit growth forecast at 22.5% per year, which would outpace the projected 15.7% growth for the US market. While revenue is expected to grow more slowly than peers, Etsy’s...
NYSE:HAYW
NYSE:HAYWBuilding

Hayward Holdings (HAYW) Margin Expansion Surpasses Expectations, Reinforcing Bullish Community Narratives

Hayward Holdings (HAYW) posted a net profit margin of 12.5%, up from 9.5% last year, and delivered earnings growth of 45.3% over the past year, well above its five-year average of 14.4% per year. Analysts expect earnings to grow at 11.9% annually moving forward, a pace that trails the broader US market forecast of 15.7%. Revenue growth is also projected to lag behind at 6.1% per year compared to the market's 10.3%. With high quality earnings and consistent profit expansion, but a slower...
NYSE:FMC
NYSE:FMCChemicals

FMC (FMC): Five-Year Losses Challenge Bullish Forecasts of 54.56% Annual Earnings Growth

FMC (FMC) remains unprofitable, with losses increasing by 3.7% per year on average over the past five years. Revenue is forecast to grow at 8% annually, which trails the broader US market’s 10.3% expectation. The company trades at a price-to-sales ratio of 0.5x, which is well below the industry average of 1.2x and its estimated fair value. Looking ahead, the real story for investors is whether the projected 54.56% annual earnings growth and discounted valuation can outweigh concerns around...
SEHK:811
SEHK:811Media

Xinhua Winshare (SEHK:811) Margin Milestone Reinforces Undervalued Earnings Narrative

Xinhua Winshare Publishing and Media (SEHK:811) delivered earnings growth of 10% over the past year, outpacing its five-year average of 6.8% per year. Net profit margin improved to 14%, up from 12.5% in the previous year, reflecting a clear boost in profitability. With earnings forecast to grow 7.17% per year and revenue at 3.4% per year, both slower than the broader Hong Kong market, investors are focused on how the company's undervalued share price and strong margins shape its investment...
NYSE:BNL
NYSE:BNLREITs

Broadstone Net Lease (BNL) Profit Margin Drops to 22.1%, Raising Questions on Earnings Quality

Broadstone Net Lease (BNL) posted a net profit margin of 22.1% for the twelve months ending September 30, 2025, down from last year’s 36.6%, after absorbing a one-off loss of $42.2 million. Earnings have grown at an average annual rate of 16.3% over the past five years, but recent results show negative growth that does not match up with that longer-term trend. Looking ahead, earnings are projected to rise 8.93% annually, and revenue growth is expected at 4.4% per year. Both figures trail the...
TSX:VBNK
TSX:VBNKBanks

3 TSX Stocks That May Be Trading Below Their Estimated Value In October 2025

As the bull market in Canada marks its third anniversary, with the TSX having gained 67% since October 2022, investors are keenly observing how cooler inflation and potential interest rate cuts might influence future growth. Amidst trade tensions and valuation concerns, identifying stocks that may be trading below their estimated value becomes crucial for those looking to capitalize on opportunities within this evolving economic landscape.